6:49 PM
 | 
May 21, 2010
 |  BC Extra  |  Company News

Temporary reprieve for Angiomax patent

The U.S. District Court for the Eastern District of Virginia ordered the U.S. Patent and Trademark Office to ensure that a patent for anticoagulant Angiomax...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >